The international drug conventions were created to ensure the “health and welfare of mankind”, yet drug policies around the world continue to focus on criminal justice and repression rather than on health responses. Governments across the world should provide harm reduction and treatment interventions to reduce the harms associated with drug use, and ensure adequate access to essential medicines.
This survey conducted by the New Zealand Drug Foundation asseses knowledge, attitudes and behaviours around driving under the influence of psychoactive substances, including illicit drugs, prescription medicines, and alcohol in New Zealand.
This submission describes several key human rights priorities and provides recommendations for Kazakhstan’s Government to better respect, protect and fulfill human rights, consistent with its international obligations, in areas of particular relevance to an effective response to HIV.
The findings from this report confirm that training of drug users constitutes a valuable resource in the management of opiate overdoses and growth of peer interventions that may not otherwise be recognised or addressed.
This note highlights the most critical issues for the UNODC Executive Director to tackle over the next two years and offers the support of the Consortium to any candidate who takes these challenges seriously.
In Indonesia, people living with HIV/AIDS (PLHAs) have for too long stigmatized and discriminated for their illness. The Indonesian National AIDS Commission (KPAN) has to play a more active role in ensuring that not just AIDS is reduced, but beyond that that PLHAs will no longer be stigmatized and…
Results from an initial overview of the randomised injectable opioid therapy trial (RIOTT) has shown that clients form a 'hard-to-treat' population responded well and made notable gains in abstaining from street heroin and improvements in health and social functioning.
The RIOTT (randomised injectable opioid therapy trial) project run by the Institute of Psychiatry in London presented an initial overview of its data at a conference this week. The trial compared treatments using optimised oral methadone, injectable methadone and injectable diamorphine